Market Opportunity
The prescription opioid market is projected to reach $35B by 2025. We believe that PPL-103 has the potential to reach annual sales of $2B by 2028 assuming less than 10% capture of US prescription volume. The company anticipates that PPL-138 has similar potential in terms of market penetration, as it will focus specifically on chronic pain. According to P&S Intelligence, the chronic pain treatment market is growing due to the rising prevalence of chronic conditions and a surging geriatric population, and is expected to reach $105.9B by 2024.